Literature DB >> 6194112

Mapping of the antigenic determinants of Pseudomonas aeruginosa PAK polar pili.

T H Watts, P A Sastry, R S Hodges, W Paranchych.   

Abstract

The polar pili of Pseudomonas aeruginosa are flexible filaments 5.2 nm in diameter and 2.5 microns in average length. They consist of a single subunit, pilin, which is a 144-residue polypeptide containing a hydrophobic N-terminal region (residues 1 to 30) and eight hydrophilic regions distributed throughout the remainder of the molecule. To delineate the antigenic regions of pilin, we cleaved the protein at Arg30, Arg53, and Arg120 to produce peptides TCI (residues 1 to 30), TCII (31 to 53), TCIII (54 to 120), and TCIV (121 to 144). TCIII and TCIV were further cleaved into several subfragments. The purified peptides were coupled to bovine serum albumin by using the N-hydroxysuccinimide ester of 4-azidobenzoic acid and were then subjected to immunological analysis, using the enzyme-linked immunosorbent assay and immunoblot procedures with polyclonal antiserum. Four antigenic regions were identified; one in TCI was found to be common to both PAK and PAO pilin. The remaining three were found to be specific to PAK pilin. Two of these were subfragments of TCIII, whereas the third was located close to the C-terminus of the molecule, most likely between Cys129 and Cys142. Modification of these cysteines by reduction and carboxymethylation of the disulfide linkage did not abolish the antigenicity of the C-terminal type-specific antigenic determinant.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6194112      PMCID: PMC264531          DOI: 10.1128/iai.42.1.113-121.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Electrophoretic resolution of the "major outer membrane protein" of Escherichia coli K12 into four bands.

Authors:  B Lugtenberg; J Meijers; R Peters; P van der Hoek; L van Alphen
Journal:  FEBS Lett       Date:  1975-10-15       Impact factor: 4.124

2.  A microplate method of enzyme-linked immunosorbent assay and its application to malaria.

Authors:  A Voller; D Bidwell; G Huldt; E Engvall
Journal:  Bull World Health Organ       Date:  1974       Impact factor: 9.408

3.  Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.

Authors:  G Fairbanks; T L Steck; D F Wallach
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

Review 4.  Strategy and tactics in protein chemistry.

Authors:  B S Hartley
Journal:  Biochem J       Date:  1970-10       Impact factor: 3.857

5.  The reaction of aldolase with 2-methylmaleic anhydride.

Authors:  I Gibbons; R N Perham
Journal:  Biochem J       Date:  1970-03       Impact factor: 3.857

6.  An improved technique for the analysis of amino acids and related compounds on thin layers of cellulose. II. The quantitative determination of amino acids in protein hydrolysates.

Authors:  J G Heathcote; C Haworth
Journal:  J Chromatogr       Date:  1969-08-05

7.  Purification and N-terminal sequence of a fimbrial protein from Moraxella nonliquefaciens.

Authors:  L O Froholm; K Sletten
Journal:  FEBS Lett       Date:  1977-01-15       Impact factor: 4.124

8.  Composition and molecular weight of pili purified from Pseudomonas aeruginosa K.

Authors:  L S Frost; W Paranchych
Journal:  J Bacteriol       Date:  1977-07       Impact factor: 3.490

9.  An immunological study of the pili of Pseudomonas aeruginosa.

Authors:  D E Bradley; T L Pitt
Journal:  J Hyg (Lond)       Date:  1975-06

10.  Neisseria pili proteins: amino-terminal amino acid sequences and identification of an unusual amino acid.

Authors:  M A Hermodson; K C Chen; T M Buchanan
Journal:  Biochemistry       Date:  1978-02-07       Impact factor: 3.162

View more
  20 in total

1.  Shared antigenicity and immunogenicity of type 4 pilins expressed by Pseudomonas aeruginosa, Moraxella bovis, Neisseria gonorrhoaea, Dichelobacter nodosus, and Vibrio cholerae.

Authors:  P Patel; C F Marrs; J S Mattick; W W Ruehl; R K Taylor; M Koomey
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

2.  Cross-reactive and strain-specific antipeptide antibodies to Pseudomonas aeruginosa PAK and PAO pili.

Authors:  K K Lee; W Paranchych; R S Hodges
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

3.  Mapping of the T-cell recognition sites of Pseudomonas aeruginosa PAK polar pili.

Authors:  W Smart; P A Sastry; W Paranchych; B Singh
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

4.  Characterization of Pseudomonas aeruginosa mutants with altered piliation.

Authors:  K Johnson; S Lory
Journal:  J Bacteriol       Date:  1987-12       Impact factor: 3.490

5.  Role of pili in adhesion of Pseudomonas aeruginosa to human respiratory epithelial cells.

Authors:  P Doig; T Todd; P A Sastry; K K Lee; R S Hodges; W Paranchych; R T Irvin
Journal:  Infect Immun       Date:  1988-06       Impact factor: 3.441

6.  Major antigenic determinants of F and ColB2 pili.

Authors:  B B Finlay; L S Frost; W Paranchych; J M Parker; R S Hodges
Journal:  J Bacteriol       Date:  1985-07       Impact factor: 3.490

7.  Immune recognition of polar pili from Pseudomonas aeruginosa O.

Authors:  W Smart; P A Sastry; W Paranchych; B Singh
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

8.  Effects of sub-MICs of erythromycin and other macrolide antibiotics on serum sensitivity of Pseudomonas aeruginosa.

Authors:  K Tateda; Y Hirakata; N Furuya; A Ohno; K Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

9.  Differentiation of Pseudomonas aeruginosa pili based on sequence and B-cell epitope analyses.

Authors:  P A Castric; C D Deal
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

10.  Identification of the mucin-binding adhesin of Pseudomonas cepacia isolated from patients with cystic fibrosis.

Authors:  S U Sajjan; J F Forstner
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.